UNMC_Acronym_Vert_sm_4c
University of Nebraska Medical Center

Category: RSV

RSV Hospitalizations Surge, Babies Hit Hardest

(WSJ) Emergency departments, pediatric hospitals are strained by unseasonably early rise in respiratory infections High rates of hospitalization with RSV are hitting the youngest children especially hard, part of an unseasonably early surge in respiratory infections. Some 3.0 people for every 100,000 were hospitalized with respiratory syncytial virus the week ended Nov. 5, according to federal […]

Nov 11, 2022

FDA Fast-Tracks Codagenix RSV Vaccine Candidate

(Contagion Live) Codagenix Inc. announced the US Food and Drug Administration (FDA) recently granted Fast Track designation to CodaVax-RSV, their respiratory syncytial virus (RSV) vaccine candidate. RSV is a common, contagious respiratory virus that attacks the lungs and breathing passageways. There is currently no approved vaccine for RSV, but an ongoing uptick in cases has led to an increased fervor of […]

Nov 7, 2022

CDC Warns on Early Wave of Respiratory Illnesses

(MedPageToday) The CDC is warning of elevated levels of non-COVID respiratory illnesses in recent weeks — including rising cases of influenza, respiratory syncytial virus (RSV), and rhinovirus. The surge stands in contrast to the lower activity of these viruses seen during the past couple of pandemic years, as a result of the various mitigation measures […]

Nov 4, 2022

EU Approves First Monoclonal Antibody To Prevent RSV In All Children As U.S. Cases Surge

(Forbes) The European Commission on Friday approved the first monoclonal antibody to prevent respiratory syncytial virus (RSV) among all infants and newborns, amid a rise of cases of the highly contagious virus, which can pose a danger to infants and older adults. The European Commission approved Beyfortus, an injection manufactured by AstraZeneca and Sanofi to […]

Nov 4, 2022

RSV Is Surging: What We Know about This Common and Surprisingly Dangerous Virus

(Scientific American) As flu season picks up and experts weigh concerns about another possible COVID surge, children’s hospitals are already filling with patients with another viral threat: respiratory syncytial virus, or RSV. Even though many people haven’t heard of RSV, pretty much everyone has had it, probably multiple times, says Anthony Flores, chief of pediatric infectious […]

Nov 4, 2022

Orange County declares health emergency as RSV surges; cases also rising in L.A.

(Los Angeles Times) Rapidly spreading viral infections have pushed pediatric hospitalizations and daily emergency room visits to record levels in Orange County, prompting officials to declare a health emergency. The county, like the rest of California, is facing a viral triple whammy: continued circulation of the coronavirus, seasonal rise of the flu and heightened spread of respiratory […]

Nov 2, 2022

What to know about RSV, a virus surging among young children in Canada

(CBC) Cases of respiratory syncytial virus rising in parts of Canada after drop early in pandemic. Children’s hospitals in Canada are seeing an increase in cases of a common respiratory virus that, in rare cases, can lead to severe illness in infants. Respiratory syncytial virus (RSV) causes infections of the lungs and respiratory tract. It […]

Nov 2, 2022

Where Will All the Sick Children Go?

(MedPageToday) A surge in viral infections among kids is straining hospital capacity across the country. On January 20 of this year, Tufts Medical Center announced it would be closing all inpatient pediatric care as of July 1. The current pediatric areas would be given over to adult services. The plan was to maintain the level 3 neonatal […]

Nov 1, 2022

Why isn’t there an RSV vaccine for kids?

(NBC News) A failed clinical trial in the late ’60s pushed the development of an RSV vaccine back decades Cases of RSV continue to surge in the U.S., but a vaccine to protect young children against the respiratory virus remains a long ways off. RSV, or respiratory syncytial virus, is the most common cause of […]

Oct 27, 2022

Vaccine Candidates for RSV Ward Off Severe Illness in Older Adults

(MedPageToday) Prefusion F protein vaccine candidates for respiratory syncytial virus (RSV) proved safe in adults 60 and up while demonstrating an ability to thwart lower respiratory tract illness, including severe cases, a pair of large phase III trials showed. A single dose of an RSV prefusion F protein vaccine (RSVPreF3 OA) yielded a vaccine efficacy […]

Oct 27, 2022